Meta-Analysis of NUDT15 Genetic Polymorphism on Thiopurine-Induced Myelosuppression in Asian Populations
Backgound: The high incidence of thiopurine-induced myelosuppression in Asians is known to be attributable to genetic variation in thiopurine metabolism. A quantitative synthesis to summarize the genetic association with thiopurine-induced myelosuppression in Asians was therefore conducted.Methods:...
Guardado en:
Autores principales: | , , , , , , , , , , , |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Frontiers Media S.A.
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/0b802fac302c4255b3dc0f00f3ef8768 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
id |
oai:doaj.org-article:0b802fac302c4255b3dc0f00f3ef8768 |
---|---|
record_format |
dspace |
spelling |
oai:doaj.org-article:0b802fac302c4255b3dc0f00f3ef87682021-12-02T11:20:34ZMeta-Analysis of NUDT15 Genetic Polymorphism on Thiopurine-Induced Myelosuppression in Asian Populations1663-981210.3389/fphar.2021.784712https://doaj.org/article/0b802fac302c4255b3dc0f00f3ef87682021-12-01T00:00:00Zhttps://www.frontiersin.org/articles/10.3389/fphar.2021.784712/fullhttps://doaj.org/toc/1663-9812Backgound: The high incidence of thiopurine-induced myelosuppression in Asians is known to be attributable to genetic variation in thiopurine metabolism. A quantitative synthesis to summarize the genetic association with thiopurine-induced myelosuppression in Asians was therefore conducted.Methods: A Literature search was performed from January 2016 to May 2021 in the following databases: PubMed, Web of Science, and Embase and addition search included the studies from Zhang et al. Two reviewers independently extracted the following data: the author’s name, year of publication, ethnicity, drugs, diseases, genetic polymorphisms, onset, type of myelosuppression and results of Hardy-Weinberg equilibrium. The Newcastle-Ottawa Scale was used to assess the quality of the studies. The pooled odds ratios (OR) and 95% confidence intervals (CI) were calculated to evaluate the associations of NUDT15 and the risk of thiopurine-induced myelosuppression stratified by onset and type of myelosuppressive. Subgroup analysis by NUDT15 genetic polymorphisms was performed.Results: A total of 30 studies was included in this meta-analysis. The overall OR for the relationship between NUDT15 genetic polymorphisms and thiopurine-induced early onset of leukopenia and neutropenia in Asian populations were 11.43 (95% CI 7.11–18.35) and 16.35 (95% CI 10.20–26.22). Among NUDT15 polymorphisms, NUDT15*3 showed a significantly increased risk of early leukopenia (OR 15.31; 95% CI 9.65–24.27) and early neutropenia (OR 15.85; 95% CI 8.80–28.53). A significantly higher thiopurine-induced early neutropenic risk was also found for NUDT15*2 (OR 37.51; 95% CI 1.99–708.69). Whereas, NUDT15*5 and NUDT15*6 variants showed a lower risk of leukopenia.Conclusion: This study suggests that NUDT15*3 and NUDT15*2 are important genetic markers of thiopurine-induced early onset of myelotoxicity in Asians, therefore, early detection of these variants before initiating thiopurine therapy is necessary.Kanyarat KhaesoSariya UdayachalermPatcharee KomvilaisakSu-on ChainansamitKunanya SuwannayingNapat LaoaroonPitchayanan KuwatjanakulNontaya NakkamChonlaphat SukasemChonlaphat SukasemApichaya PuangpetchApichaya PuangpetchWichittra TassaneeyakulNathorn ChaiyakunaprukFrontiers Media S.A.articlenucleoside diphosphate–linked moiety X-type motif 15 (NUDT15)thiopurine drugshematotoxicitygenetic polymorphismprecision medicineMeta-analysisTherapeutics. PharmacologyRM1-950ENFrontiers in Pharmacology, Vol 12 (2021) |
institution |
DOAJ |
collection |
DOAJ |
language |
EN |
topic |
nucleoside diphosphate–linked moiety X-type motif 15 (NUDT15) thiopurine drugs hematotoxicity genetic polymorphism precision medicine Meta-analysis Therapeutics. Pharmacology RM1-950 |
spellingShingle |
nucleoside diphosphate–linked moiety X-type motif 15 (NUDT15) thiopurine drugs hematotoxicity genetic polymorphism precision medicine Meta-analysis Therapeutics. Pharmacology RM1-950 Kanyarat Khaeso Sariya Udayachalerm Patcharee Komvilaisak Su-on Chainansamit Kunanya Suwannaying Napat Laoaroon Pitchayanan Kuwatjanakul Nontaya Nakkam Chonlaphat Sukasem Chonlaphat Sukasem Apichaya Puangpetch Apichaya Puangpetch Wichittra Tassaneeyakul Nathorn Chaiyakunapruk Meta-Analysis of NUDT15 Genetic Polymorphism on Thiopurine-Induced Myelosuppression in Asian Populations |
description |
Backgound: The high incidence of thiopurine-induced myelosuppression in Asians is known to be attributable to genetic variation in thiopurine metabolism. A quantitative synthesis to summarize the genetic association with thiopurine-induced myelosuppression in Asians was therefore conducted.Methods: A Literature search was performed from January 2016 to May 2021 in the following databases: PubMed, Web of Science, and Embase and addition search included the studies from Zhang et al. Two reviewers independently extracted the following data: the author’s name, year of publication, ethnicity, drugs, diseases, genetic polymorphisms, onset, type of myelosuppression and results of Hardy-Weinberg equilibrium. The Newcastle-Ottawa Scale was used to assess the quality of the studies. The pooled odds ratios (OR) and 95% confidence intervals (CI) were calculated to evaluate the associations of NUDT15 and the risk of thiopurine-induced myelosuppression stratified by onset and type of myelosuppressive. Subgroup analysis by NUDT15 genetic polymorphisms was performed.Results: A total of 30 studies was included in this meta-analysis. The overall OR for the relationship between NUDT15 genetic polymorphisms and thiopurine-induced early onset of leukopenia and neutropenia in Asian populations were 11.43 (95% CI 7.11–18.35) and 16.35 (95% CI 10.20–26.22). Among NUDT15 polymorphisms, NUDT15*3 showed a significantly increased risk of early leukopenia (OR 15.31; 95% CI 9.65–24.27) and early neutropenia (OR 15.85; 95% CI 8.80–28.53). A significantly higher thiopurine-induced early neutropenic risk was also found for NUDT15*2 (OR 37.51; 95% CI 1.99–708.69). Whereas, NUDT15*5 and NUDT15*6 variants showed a lower risk of leukopenia.Conclusion: This study suggests that NUDT15*3 and NUDT15*2 are important genetic markers of thiopurine-induced early onset of myelotoxicity in Asians, therefore, early detection of these variants before initiating thiopurine therapy is necessary. |
format |
article |
author |
Kanyarat Khaeso Sariya Udayachalerm Patcharee Komvilaisak Su-on Chainansamit Kunanya Suwannaying Napat Laoaroon Pitchayanan Kuwatjanakul Nontaya Nakkam Chonlaphat Sukasem Chonlaphat Sukasem Apichaya Puangpetch Apichaya Puangpetch Wichittra Tassaneeyakul Nathorn Chaiyakunapruk |
author_facet |
Kanyarat Khaeso Sariya Udayachalerm Patcharee Komvilaisak Su-on Chainansamit Kunanya Suwannaying Napat Laoaroon Pitchayanan Kuwatjanakul Nontaya Nakkam Chonlaphat Sukasem Chonlaphat Sukasem Apichaya Puangpetch Apichaya Puangpetch Wichittra Tassaneeyakul Nathorn Chaiyakunapruk |
author_sort |
Kanyarat Khaeso |
title |
Meta-Analysis of NUDT15 Genetic Polymorphism on Thiopurine-Induced Myelosuppression in Asian Populations |
title_short |
Meta-Analysis of NUDT15 Genetic Polymorphism on Thiopurine-Induced Myelosuppression in Asian Populations |
title_full |
Meta-Analysis of NUDT15 Genetic Polymorphism on Thiopurine-Induced Myelosuppression in Asian Populations |
title_fullStr |
Meta-Analysis of NUDT15 Genetic Polymorphism on Thiopurine-Induced Myelosuppression in Asian Populations |
title_full_unstemmed |
Meta-Analysis of NUDT15 Genetic Polymorphism on Thiopurine-Induced Myelosuppression in Asian Populations |
title_sort |
meta-analysis of nudt15 genetic polymorphism on thiopurine-induced myelosuppression in asian populations |
publisher |
Frontiers Media S.A. |
publishDate |
2021 |
url |
https://doaj.org/article/0b802fac302c4255b3dc0f00f3ef8768 |
work_keys_str_mv |
AT kanyaratkhaeso metaanalysisofnudt15geneticpolymorphismonthiopurineinducedmyelosuppressioninasianpopulations AT sariyaudayachalerm metaanalysisofnudt15geneticpolymorphismonthiopurineinducedmyelosuppressioninasianpopulations AT patchareekomvilaisak metaanalysisofnudt15geneticpolymorphismonthiopurineinducedmyelosuppressioninasianpopulations AT suonchainansamit metaanalysisofnudt15geneticpolymorphismonthiopurineinducedmyelosuppressioninasianpopulations AT kunanyasuwannaying metaanalysisofnudt15geneticpolymorphismonthiopurineinducedmyelosuppressioninasianpopulations AT napatlaoaroon metaanalysisofnudt15geneticpolymorphismonthiopurineinducedmyelosuppressioninasianpopulations AT pitchayanankuwatjanakul metaanalysisofnudt15geneticpolymorphismonthiopurineinducedmyelosuppressioninasianpopulations AT nontayanakkam metaanalysisofnudt15geneticpolymorphismonthiopurineinducedmyelosuppressioninasianpopulations AT chonlaphatsukasem metaanalysisofnudt15geneticpolymorphismonthiopurineinducedmyelosuppressioninasianpopulations AT chonlaphatsukasem metaanalysisofnudt15geneticpolymorphismonthiopurineinducedmyelosuppressioninasianpopulations AT apichayapuangpetch metaanalysisofnudt15geneticpolymorphismonthiopurineinducedmyelosuppressioninasianpopulations AT apichayapuangpetch metaanalysisofnudt15geneticpolymorphismonthiopurineinducedmyelosuppressioninasianpopulations AT wichittratassaneeyakul metaanalysisofnudt15geneticpolymorphismonthiopurineinducedmyelosuppressioninasianpopulations AT nathornchaiyakunapruk metaanalysisofnudt15geneticpolymorphismonthiopurineinducedmyelosuppressioninasianpopulations |
_version_ |
1718395978470391808 |